EUVIMEDEUVIMED entdecken
Fallbericht

“Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”

Raffaele Ferri, Katia Falasca iD, Jacopo Vecchiet, Claudio Ucciferri

International Journal of STD & AIDS · 2025

DOI: 10.1177/09564624251327237 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Raffaele Ferri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University "G. D'Annunzio", Chieti, Italy. Hauptthemen laut MEDLINE: HIV Infections, Dyslipidemias, Hypolipidemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dyslipidemia in people living with HIV differs from the general population because combination antiretroviral therapy may not only induce dyslipidemia but also interact with lipid-lowering agents. Monoclonal antibodies that target proprotein convertase subtilisin/kexin type 9 (PCSK9) have recently been demonstrated to dramatically reduce LDL-C level (>60%) in the majority of cases, and another interesting new option is inclisiran, a first-in-class, cholesterol-lowering small interfering RNA (siRNA) targeting PCSK9 mRNA and conjugated to triantennary N-acetylgalactosamine carbohydrates (GalNAc). We present the clinical case of a 62-year-old man living with HIV and dyslipidemia in whom new hypolipidemic drugs were fundamental in achieving adequate LDL values to prevent cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDyslipidemiasHypolipidemic AgentsHumansMaleMiddle AgedCholesterol, LDLTreatment OutcomeProprotein Convertase 9RNA, Small Interfering

Stichwörter der Autor:innen

Bempedoic aciddyslipidemiainclisiranstatins

Substanzen

Cholesterol, LDLHypolipidemic AgentsPCSK9 protein, humanProprotein Convertase 9RNA, Small Interfering

Autor:innen und Institutionen

  • Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University "G. D'Annunzio", Chieti, Italy.

ORCID-Profile: Katia Falasca

Zitieren

APA

Ferri, R., Falasca, K., Vecchiet, J., & Ucciferri, C. (2025). “Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251327237

Vancouver

Ferri R, Falasca K, Vecchiet J, Ucciferri C. “Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251327237

BibTeX
@article{Ferri2025,
  author = {Ferri, Raffaele and Falasca, Katia and Vecchiet, Jacopo and Ucciferri, Claudio},
  title = {“Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”},
  journal = {International Journal of STD & AIDS},
  year = {2025},
  doi = {10.1177/09564624251327237}
}
Kostenlos starten →